Clinical Trials Directory

Trials / Conditions / NSCLC (Non-small Cell Lung Carcinoma)

NSCLC (Non-small Cell Lung Carcinoma)

9 registered clinical trials studyying NSCLC (Non-small Cell Lung Carcinoma) — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingFirmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary A
NCT07314216
Hunan Cancer HospitalPhase 2
RecruitingLow Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastati
NCT07050043
Dr Arvindran A/L AlagaPhase 3
RecruitingStudy of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784
Revolution Medicines, Inc.Phase 3
Active Not RecruitingA Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lu
NCT06685718
BeOne MedicinesPhase 1
Active Not RecruitingA Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in
NCT05456867
AstraZeneca—
WithdrawnItacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor R
NCT02355431
Incyte CorporationPhase 2
TerminatedA Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously T
NCT02298153
Incyte CorporationPhase 1
TerminatedStudy of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
NCT02257619
Incyte CorporationPhase 2
TerminatedRuxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
NCT02119650
Incyte CorporationPhase 2